Skip to Content

Survanta Intratracheal Side Effects

Generic Name: beractant

Note: This page contains side effects data for the generic drug beractant. It is possible that some of the dosage forms included below may not apply to the brand name Survanta Intratracheal.

It is possible that some side effects of Survanta Intratracheal may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

For the Consumer

Applies to beractant: intratracheal suspension

Side effects include:

Transient bradycardia, oxygen desaturation, endotracheal tube reflux, pallor, vasoconstriction, hypotension, endotracheal tube blockage, hypertension, hypocarbia, hypercarbia, apnea.

For Healthcare Professionals

Applies to beractant: intratracheal suspension

General

The most commonly reported adverse experiences were associated with the dosing procedure; transient bradycardia occurred with 11.9% of doses and oxygen desaturation occurred with 9.8% of doses.[Ref]

Cardiovascular

Very common (10% or more): Transient bradycardia (11.9%)
Uncommon (0.1% to 1%): Pallor, vasoconstriction, hypotension, hypertension, hypercarbia, hypocarbia
Frequency not reported: Tachycardia, ventricular tachycardia, aortic thrombosis, cardiac failure, cardio-respiratory arrest, increased apical pulse, persistent fetal circulation, air embolism, total anomalous pulmonary venous return[Ref]

Respiratory

Common (1% to 10%): Oxygen desaturation
Uncommon (0.1% to 1%): Apnea
Frequency not reported: Lung consolidation, blood from the endotracheal tube, deterioration after weaning, respiratory decompensation, subglottic stenosis, paralyzed diaphragm, respiratory failure[Ref]

Gastrointestinal

Uncommon (0.1% to 1%): Endotracheal tube reflux, endotracheal tube blockage
Frequency not reported: Abdominal distension, hemorrhage, intestinal perforations, volvulus, bowel infarct, feeding intolerance, stress ulcer[Ref]

Endocrine

Frequency not reported: Adrenal hemorrhage, inappropriate ADH secretion, hyperphosphatemia[Ref]

Hematologic

Frequency not reported: Coagulopathy, thrombocytopenia, disseminated intravascular coagulation[Ref]

Hepatic

Frequency not reported: Hepatic failure[Ref]

Musculoskeletal

Frequency not reported: Inguinal hernia[Ref]

Nervous system

Frequency not reported: Seizures[Ref]

Renal

Frequency not reported: Renal failure, hematuria[Ref]

References

1. "Product Information. Survanta Intratracheal (beractant)." Abbott Pharmaceutical, Abbott Park, IL.

More about Survanta Intratracheal (beractant)

Consumer resources

Professional resources

Other formulations

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide